NCT06569485View on ClinicalTrials.gov

A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma Patients

PHASE2RecruitingINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

May 23, 2024

Primary Completion Date

December 30, 2024

Study Completion Date

December 1, 2027

Conditions
DLBCL
Interventions
DRUG

Trilaciclib+R-CHOP

This is a prospective, single-arm, multi-center, phase II clinical study to evaluate the efficacy and safety of Trilaciclib in DLBCL patients treated with R-CHOP.

Trial Locations (1)

510060

RECRUITING

Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER